Prescriber is the leading UK journal for healthcare professionals focussing on prescribing and medicines management. The journal features articles on all areas of therapeutics and prescribing policy and is fully peer reviewed. The content is relevant and of interest to all prescribers and prescribing policy makers including GPs, pharmacists, nurses and hospital specialists. Access to all content is free to healthcare professionals following registration.Sign up for e-alerts and print copies

Latest News

CHMP recommends brolucizumab for neovascular AMD

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended the granting of a marketing authorisation for a new anti-neovascularisation...Read more

Domperidone no longer licensed for children under 12 years

The Medicines and Healthcare products Regulatory Agency (MHRA) has advised prescribers that domperidone is no longer licensed for use in children younger than...Read more

Apalutamide licence extension to include metastatic prostate cancer

The CHMP has recommended an extension to the marketing authorisation of apalutamide (Erleada), to include men with metastatic hormone-sensitive prostate...Read more

Ustekinumab licence extension to include children over six years with psoriasis

The CHMP has recommended that the marketing authorisation for ustekinumab (Stelara) be extended to use in children with moderate to severe plaque psoriasis...Read more

NICE updates guidance on cladribine for MS

NICE has published an update to its technology appraisal guidance (TA616) on oral cladribine (Mavenclad) for treating highly active relapsing-remitting...Read more

Featured Articles

Diagnosis, assessment and management of osteoporosis
Osteoporosis is a common condition, especially in postmenopausal women, but it often remains undetected until after fracture occurs. This article discusses its diagnosis, fracture risk assessment and recommended management.
Click here to view

Autism in children: improving screening, diagnosis and support
Although symptoms of autism often first appear before the age of three years, many children experience significant delays in identification, diagnosis and access to specialist services. This article discusses the signs and symptoms of autism in children, screening and referral, and the management options available.
Click here to view

Managing polypharmacy: teamwork in general practice
Regular medication review has an important role in preventing patient harm from inappropriate polypharmacy. This article discusses how effective teamwork among healthcare professionals, including GPs, pharmacists and nurses working in general practice, can optimise patient outcomes.
Click here to view

Web design and marketing agency Leamington Spa